Justification of the efficacy of antibacterial therapy for the treatment of chronic endometritis

Cover Page
  • Authors: Tapilskaya N.I.1, Karpeyev S.A.2, Gaidukov S.N.1
  • Affiliations:
    1. St. Petersburg State Pediatric Medical University (State Budgetary Educational Institution for Higher Professional education), Ministry of Healthcare of the Russian Federation
    2. «Konsul'tativno-diagnosticheskij centr s poliklinikoj» Upravlenija delami Prezidenta RF
  • Issue: Vol 91, No 2 (2015)
  • Pages: 130-138
  • Section: DRUG TREATMENT IN DERMATOVENEROLOGY
  • URL: https://www.vestnikdv.ru/jour/article/view/133
  • DOI: https://doi.org/10.25208/0042-4609-2015-91-2-130-138

Abstract


A review of studies on chronic endometritis enables the authors to conclude that bacterially contaminated endometrium is the reason causing reduced fertility in case of confirmed subclinical inflammation. Chronic subclinical inflammation of the endometrium is often associated with genital endometriosis, which apparently leads to abnormal uterine bleedings. The identification of a microbial agent in case of endometritis in the routine outpatient practice is not mandatory because global experience including high-level evidence-based studies confirms the expediency of an empirical therapy based on minimum clinical criteria; otherwise, there may be irreversible consequences for the reproductive system. A preventive antibacterial therapy during the pre-conception period in infertile patients suffering from recurrent miscarriages is an efficient method to prevent reproductive losses.

N. I. Tapilskaya

St. Petersburg State Pediatric Medical University (State Budgetary Educational Institution for Higher Professional education), Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: tapnatalia@yandex.ru

Russian Federation

S. A. Karpeyev

«Konsul'tativno-diagnosticheskij centr s poliklinikoj» Upravlenija delami Prezidenta RF

Email: noemail@neicon.ru

Russian Federation

S. N. Gaidukov

St. Petersburg State Pediatric Medical University (State Budgetary Educational Institution for Higher Professional education), Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru

Russian Federation

  1. Wiesenfeld H.C., Hillier S.L., Meyn L.A., Amortegui A.J., Sweet R.L. Subclinical pelvic inflammatory diseaseand infertility. Obstet Gynecol 2012; 120: 37-43
  2. Радзинский В.Е. Димитрова В.И. Майскова И.Ю. Неразвивающаяся беременность. M.: Геотар-Медиа 2009; 196
  3. Munro M.G., Critchley H.O., Broder M.S., Fraser I.S.; FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113 (1): 3-13
  4. Cicinelli E., Tinelli R., Lepera A., Pinto V., Fucci M., Resta L. Correspondence between hysteroscopic and histologic findings in women with chronic endometritis. Acta Obstet Gynecol Scand 2010; 89 (8): 1061-5
  5. Haggerty C.L. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis 2008; 21 (1): 65-9.
  6. Hillier S.L., Rabe L.K., Meyn L., Macio I., Trucco G., Amortegui A., Darville T., Wiesenfeld H.C. Endometrial Gardnerella vaginalis and Atopobium Vaginea are associated with histologic endometritis among women with clinically diagnosed pelvic inflammatory disease (PID). Sex Transm Infect 2013; 89 (1): A36.
  7. Espinoza J., Erez O., Romero R. Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery. Am J Obstet Gynecol 2006; 194 (3): 630-7.
  8. Cicinelli E., De Ziegler D., Nicoletti R., Colafiglio G., Saliani N., Resta L., Rizzi D., De Vito D. Chronic endometritis: correlation among hysteroscopic, histologic, and bacteriologic findings in a prospective trial with 2190 consecutive office hysteroscopies. Fertil Steril 2008; 89 (3): 677-84.
  9. Cicinelli E., De Ziegler D., Nicoletti R., Tinelli R., Saliani N., Resta L., Bellavia M., De Vito D. Poor reliability of vaginal and endocervical cultures for evaluating microbiology of endometrial cavity in women with chronic endometritis. Gynecol Obstet Invest 2009; 68 (2): 108-15.
  10. Cicinelli E., Ballini A., Marinaccio M., Poliseno A., Coscia M.F., Monno R., De Vito D. Microbiological findings in endometrial specimen: our experience. Arch Gynecol Obstet 2012; 285 (5): 1325-9.
  11. Swidsinski A., Verstraelen H., Loening-Baucke V., Swidsinski S., Mendling W., Halwani Z. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PLoS One 2013; 8 (1): e53997.
  12. Rockx B., Winegar R., Freiberg A.N. Recent progress in henipavirus research: molecular biology, genetic diversity, animal models. Antiviral Res 2012; 95 (2): 135-49.
  13. Cicinelli E., Matteo M., Tinelli R., Pinto V., Marinaccio M., Indraccolo U., De Ziegler D., Resta L. Chronic Endometritis Due to Common Bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reproductive Sciences 2014; 21 (5): 640-7.
  14. Dana B. McQueen, M.D., Lia A. Bernardi, M.D and Mary D. Stephenson, M.D., M.Sc. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril 2014; 101 (4): 1026-30.
  15. Takebayashi A., Kimura F., Kishi Y., Ishida M., Takahashi A., Yamanaka A., Takahashi K., Suginami H., Murakami T. The association between endometriosis and chronic endometritis. PLoS One 2014; 18; 9 (2): e88354.
  16. Khan K.N., Fujishita A., Kitajima M., Hiraki K., Nakashima M., Masuzaki H. Intra-uterine microbial colonization and occurrence of endometritis in women with endometriosis. Hum Reprod 2014; 29 (11): 2446-56.
  17. Johnston-MacAnanny E.B., Hartnett J., Engmann L.L., Nulsen J.C., Sanders M.M., Benadiva C.A. Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril 2010; 93 (2): 437-41.
  18. Di Pietro C., Cicinelli E., Guglielmino M.R., Ragusa M., Farina M., Palumbo M.A., Cianci A. Altered transcriptional regulation of cytokines, growth factors, and apoptotic proteins in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol 2013; 69 (5): 509-17.
  19. Tortorella C., Piazzolla G., Matteo M., Pinto V., Tinelli R., Sabbà C., Fanelli M., Cicinelli E. Interleukin-6, interleukin-1 β, and tumor necrosis factor α in menstrual effluents as biomarkers of chronic endometritis. Fertil Steril 201; 101 (1): 242-7.
  20. Christoffersen M., Woodward E., Bojesen A.M., Jacobsen S., Petersen M.R., Troedsson M.H., Lehn-Jensen H. Inflammatory responses to induced infectious endometritis in mares resistant or susceptible to persistent endometritis. BMC Vet Res 2012; 8: 41.
  21. Dewi F.N., Wood C.E., Lampe J.W., Hullar M.A., Franke A.A., Golden D.L., Adams M.R., Cline J.M. Endogenous and exogenous equol are antiestrogenic in reproductive tissues of apolipoprotein e-null mice. J Nutr 2012; 142 (10): 1829-35.
  22. Baston-Büst D.M., Götte M., Janni W., Krüssel J.S., Hess A.P. Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns. Reprod Biol Endocrinol 2010; 8: 133.
  23. Teng Y.H., Aquino R.S., Park P.W. Molecular functions of syndecan-1 in disease. Matrix Biol 2012; 31 (1): 3-16.
  24. Karasneh G.A., Ali M., Shukla D. An important role for syndecan-1 in herpes simplex virus type-1 induced cell-to-cell fusion and virus spread. PLoS One 2011; 6 (9): e25252.
  25. Antoine T.E., Park P.J., Shukla D. Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics. Rev Med Virol 2013; 23 (3): 194-208.
  26. Kitaya K., Tada Y., Hayashi T., Taguchi S., Funabiki M., Nakamura Y. Comprehensive endometrial immunoglobulin subclass analysis in infertile women suffering from repeated implantation failure with or without chronic endometritis. Am J Reprod Immunol 2014; 72 (4): 386-91.
  27. Yoshii N., Hamatani T., Inagaki N., Hosaka T., Inoue O., Yamada M., Machiya R., Yoshimura Y., Odawara Y. Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity. Reprod Biol Endocrinol 2013; 11: 37.
  28. Yang R., Du X., Wang Y., Song X., Yang Y., Qiao J. The hysteroscopy and histological diagnosis and treatment value of chronic endometritis in recurrent implantation failure patients. Arch Gynecol Obstet 2014; 289 (6): 1363-9.
  29. Aydogan P., Kahyaoglu S., Saygan S., Kaymak O., Mollamahmutoglu L., Danisman N. Does cervical ureaplasma/mycoplasma colonization increase the lower uterine segment bleeding risk during cesarean section among patients with placenta previa? A cross-sectional study. Eur Rev Med Pharmacol Sci 2014; 18 (16): 2243-7.
  30. Amsden G.W. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005; 55 (1): 10-21.
  31. Ortega E., Escobar M.A., Gaforio J.J., Algarra I., Alvarez De Cienfuegos G. Modification of phagocytosis and cytokine production in peritoneal and splenic murine cells by erythromycin A, azithromycin and josamycin. J Antimicrob Chemother 2004; 53 (2): 367-70.
  32. Khan S., Tøndervik A., Sletta H., Klinkenberg G., Emanuel C., Onsøyen E., Myrvold R., Howe R.A., Walsh T.R., Hill K.E., Thomas D.W. Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics. Antimicrob Agents Chemother 2012; 56 (10): 5134-41.
  33. Kanoh S., Rubin B.K. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010; 23 (3): 590-615. 138^ № 2, 2015
  34. Donath E., Chaudhry A., Hernandez-Aya L.F., Lit L. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease. Respir Med 2013; 107 (9): 1385-92.
  35. Leli C., Mencacci A., Bombaci J.C., D'Alò F., Farinelli S., Vitali M., Montagna P., Bietolini C., Meucci M., Perito S., Bistoni F. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients. Infez Med 2012; 20 (2): 82-7.
  36. De Francesco M.A., Caracciolo S., Bonfanti C., Manca N. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother 2013; 19 (4): 621-7.
  37. Гущин А.Е., Бурцев О.А., Рыжих П.Г. и др. Мониторинг лечения пациентов с инфекцией, вызванной Mycoplasma genitalium, с помощью методов ПЦР и НАСБДвреальном времени. Клин. дерматол. венерол. 2009; (4): 58-63
  38. Horner P., Blee K., Adams E. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! Curr Opin Infect Dis 2014; 27 (1): 68-74
  39. Silva M.J., Florêncio G.L., Gabiatti J.R., Amaral R.L., Eleutério Jùnior J., Gonçalves A.K. Perinatal morbidity and mortality associated with chlamydial infection: a meta-analysis study. Braz J Infect Dis 2011; 15 (6): 533-9
  40. sti.bmj.com
  41. Радзинский В.Е. Репродуктивная инфектология XXI века. StatusPraesens 2013; 16 (5): 33-36

Views

Abstract - 84

PDF (Russian) - 37

Refbacks

  • There are currently no refbacks.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies